chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The rash is not itchy, it's just red and scaly.; it has progressed to a scaly, plaque like looking rash over the knuckles; small reddish areas over the knuckles on his left hand which is the side where the vaccine was administered; The rash is not itchy, it's just red and scaly.; She states her 10 year old son received the Pfizer COVID 19 vaccine; it feels dry and and it's catching on things.; This is a spontaneous report received from contactable reporter(s) (Physician) from medical information team for a Pfizer sponsored program (159558). The reporter is the parent.  A 10-year-old male patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 06Nov2021 (Lot number: FK5127) at the age of 10 years as dose 1, single for covid-19 immunization. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: ERYTHEMA (non-serious) with onset 07Nov2021, outcome "unknown", described as "small reddish areas over the knuckles on his left hand which is the side where the vaccine was administered"; RASH ERYTHEMATOUS (non-serious) with onset 07Nov2021, outcome "unknown", RASH (non-serious) with onset 08Nov2021, outcome "unknown" and all described as "The rash is not itchy, it's just red and scaly."; SKIN PLAQUE (non-serious) with onset 08Nov2021, outcome "unknown", described as "it has progressed to a scaly, plaque like looking rash over the knuckles"; FEELING ABNORMAL (non-serious) with onset Nov2021, outcome "unknown", described as "it feels dry and and it's catching on things."; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious) with onset 06Nov2021, outcome "unknown", described as "She states her 10 year old son received the Pfizer COVID 19 vaccine".  Additional information: As noted in the Fact Sheet for Recipients, you should not get the Pfizer-BioNTech COVID-19 Vaccine if you had a severe allergic reaction after a previous dose of the vaccine or if you had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. In a clinical study in children 5 through 11 years of age who received Pfizer COVID-19 Vaccine containing 10 mcg of a nucleoside-modified messenger RNA encoding the viral spike (S) glycoprotein of SARS-CoV-2 (10 mcg modRNA) adverse reactions following administration of any primary series dose included rash (0.3%). Warm transfer 159558. Upon transfer, the caller states she is calling to report these side effects.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient called on 11/14/2017 stating that he "didn't feel right". He stated he had no fever, rash, swelling, no diarrhea, or headache. On 11/15/2017 his wife called stating that he now had diarrhea and seemed to be "going in and out of consciousness".  Since they were now already in the ER waiting to be seen, we asked that they keep us posted with how he was doing.
Initial information received on 30-Nov-2018 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 2.5 months old female patient who received 0.25 mL dose of vaccine PENTACEL lot 05401AA via intramuscular route in the right thigh on 29-Nov-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was a case of actual medication error due to Expired vaccine used and vaccine underdose. It was reported that the patient received 0.25 ml of an expired dose of PENTACEL yesterday. It was unknown if any adverse event was occurred. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Pain in Left Arm, Headache, Body Aches, Joint Pain, Nausea all began the day after the injection which was a Tuesday; Friday night began chills and fever to 102.2 and nausea and vomiting increased leading to dehydration; Saturday night developed Cellulitis in Left Lower Leg
Itching; Pain in upper body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and PAIN (Pain in upper body) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PRURITUS (Itching) and PAIN (Pain in upper body). The patient was treated with ACETAMINOPHEN for Pain, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching) and PAIN (Pain in upper body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
204/108 HR 76 at 11:40am, Headache , Diaphoresis 200/15 HR 72 O2 sat  99% at 11:51  Pt refused to be transported said her husband will take her to ER
Chest pain in sternum, 3-6 days after vaccination Hip pain,  3-6 days after vaccination Lower Back pain, 8 hours after vaccination Fever 8 hours after vaccination (lasted 24 hours) Temps ranged from 99.9 to 101.5 Irregular Menstrual cycle (10 days early)  All symptoms resolved to normal a week after vaccination.  The menstrual cycle has not yet returned to normal as not enough time has passed yet to confirm.
Muscular pain near the injection site (top left arm) NOT on the injection site. Pain is similar to sore pain after exercising. Pain is consistent daily but only when I move my arm in a certain direction (lifting  my left arm and elbow higher than my shoulder and towards the back, as if trying to wear a jacket). I do not have pain if I do not move my arm in that direction and the pain is similar to muscle pain after working out. It started the morning of the first dose and it remains until today. I did not take any medication or treated the pain in any way.
Small itchy patch of skin on face that continued to grow in ring like pattern on face. Went to dermatologist in August after it continued to grow and get more red.
"Covid Arm" - Itchy swelling on  arm injection  was received , onset approximately 9 days after vaccination. Headache and general feeling of tiredness at same time.
STARTED AROUND 12:30PM ON 4/5/21: REDNESS, SORE, NODULE, BLISTERS AT INJECTION SITE, RED ARM.  TOOK TYLENOL AND IBUPROFEN
High fever happened two times after shots. First time from 06/19/03 to 06/22/03 (up to 104 F) and rush on back,neck,chest,abdomen,ect.This time from 06/25/03 up to now and lymphadenectasis and high fever around 103F and medicine (tylenol and motrin) are no good help to relieve the fever at the this time.
On 7/19/2022 Pt had sore throat and on 7 symptoms of a cold. On 7/20/2022 Pt was tested positive for Covid. Pt was prescribed Paxlovid by doctor.
arm swelling; arm red; arm hot; welt; This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced swelling arm, erythema of extremities, skin warm and welts. On an unknown date, the outcome of the swelling arm, erythema of extremities, skin warm and welts were unknown.   It was unknown if the reporter considered the swelling arm, erythema of extremities, skin warm and welts to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter reported that her arm was swollen, red and very hot following Shingrix. The welt was 6 to 7 inches long. The patient stated that 3 other people she spoke with had the same reaction as her. The patient did not provide any additional information, though she still wanted to be reimbursed for the vaccine. This case has been linked to US2019AMR068938, US2019AMR068954, US2019AMR068953 reported by same reporter.
Body ache; Headache; Joint pain; Fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of MYALGIA (Body ache), HEADACHE (Headache), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 11j20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included LEVOTHYROXINE and ESTROGENS CONJUGATED (PREMARIN) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced MYALGIA (Body ache), HEADACHE (Headache), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue). At the time of the report, MYALGIA (Body ache), HEADACHE (Headache), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jan-2021: Follow-up received on 14-JAN-2021, included no new information.
Feeling weak, and chilled, followed by temperature, later rash, small itchy bumps on hands and feet, swollen joints, weak muscles, and headaches.
Menveo was given in error today. Given booster on 8/31/20 and should not have received this vaccine. No adverse reaction from patient at this time.
Low grade temperature (101F); Mylagia (aches); upper arm soreness; Large indintation; localized with large erythematous area. Benadryl 50mg iv administered. Discharged home follwoing day - do not believe that the discharge was delayed.
Reported on 9/29 of still experiencing pain, numbness, in right arm starting at shoulder, down to finger tips. She states she felt it as soon as she rec'd vaccines in right arm, but thought it would go away. It has not increased in discomfort but is still present.
Left arm started hurting me the day after the vaccine and everyday the pain got worse it travel in to my neck and back side of my upper back. On 01/12/2021 couldn't go to work due to the pain been higher and I couldn't turn my neck to the left side
patient experienced a vasovagal type reaction within minutes of receiving vaccine. He fainted and bumped his head on the floor. He came to within seconds of fainting and had not realized he had fainted. An ice pack was given to the patient to hold to his left eyebrow bone (where he hit the ground) in order to reduce swelling. He was guided into a chair and observed for about 20 minutes when he wanted to leave the pharmacy.  The patient felt well shortly after the fall. I checked in with him 2 hours later and he still felt well.
Worsening of tinnitus, keeps me up at night, ears have been swollen after vaccine, unable to comfortable wear hearing aids since vaccine. Have an appointment with hearing doctor on the 28APR2021 to try to get relief. Do not feel I will be able to complete the vaccine series due to this reaction.
Pt recvd 1st dose of Hep B vax 26MAR91 & immediately following vax pt exp burning @ inject site accompanied by a taste in the back of throat; 1/2 hr later had tightness in chest, difficulty in breathing & weak, clammy & pale; taken to ER;
24 days subsequent to receiving varicella virus vaccine live the pt developed pruritic macular, papular, vesicular skin rash on face, trunk and scalp. The rash appears in patches and is characteristic of varicella. Pt was treated with Famvir.
Afternoon of 5AUG91 pt recvd DTP in LD-that night temp 104-106 AX; APAP brought temp down to 101.8 to 102; Site began to get red-next day more red mom notified sm pus like blister @ site; Seen by MD 7AUG91 put on ATB;
had shingles shot still got shingles/suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had shingles shot still got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 24-MAR-2023 The case was received from the patient via interactive digital media. The patient had his or her shingles shots also but still got the shingles. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
On 9/14/00, the baby was found blue and not breathing at 12:30 PM. Baby had been put to sleep at 10:30 am. Paramedics were unable to intubate due to rigor mortis. Taken to the ER and pronounced dead on arrival as pt was in asystole.
Loss of circulation/feeling in vaccinated arm, onset within 40 minutes, lasting two and a half hours.  Nausea, onset within one hour, lasting 30 hours.  Severe headache, onset within 18 hours, lasting 54 hours.  Body aches, onset within three hours, lasting 60 hours. Fever of 99.7F, onset within two hours, lasting 48 hours. Rash on vaccinated arm, lasting 60 hours.
Information has been received from a health care worker concerning a 56 year old female with penicillin and codeine allergies and a history of rash and swelling with a pneumonia vaccine in 1999 who on 10/20/2004 was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide vaccine.  Concomitant therapy included Ambien, Methocarbamol and Rabeprazole sodium.  On 10/21/2004 the patient developed a rash and swelling from the deltoid down to her elbow.  The patient sought medical attention and was given an unspecified antibiotic.  At the time of this report, the outcome was unknown.  The healthcare worker reported another patient who had a similar reaction post vaccination with pneumococcal 23v polysaccharide vaccine.  Additional information has been requested.
One week after I got the shot I started to feel pain in my armpit and I still having pain. I would like to know if it is normal? for how long I'll feel this pain?
Was scheduled for 2nd dose 10Apr2021, caller felt body was not in best shape to receive dose, so declined vaccine; Seizure like activity; Jaw pain; Chest pain; Shortness of breath; Soreness to arm at site of injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SEIZURE LIKE PHENOMENA (Seizure like activity) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Seizure like phenomena since an unknown date. Concurrent medical conditions included Brain neoplasm malignant. Concomitant products included LACOSAMIDE (VIMPAT) and PREDNISONE for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath) and VACCINATION SITE PAIN (Soreness to arm at site of injection). On 18-Mar-2021, the patient experienced PAIN IN JAW (Jaw pain) and CHEST PAIN (Chest pain). On 02-Apr-2021, the patient experienced SEIZURE LIKE PHENOMENA (Seizure like activity) (seriousness criterion medically significant). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Was scheduled for 2nd dose 10Apr2021, caller felt body was not in best shape to receive dose, so declined vaccine). At the time of the report, SEIZURE LIKE PHENOMENA (Seizure like activity), PAIN IN JAW (Jaw pain), CHEST PAIN (Chest pain), DYSPNOEA (Shortness of breath), VACCINATION SITE PAIN (Soreness to arm at site of injection) and INTENTIONAL PRODUCT USE ISSUE (Was scheduled for 2nd dose 10Apr2021, caller felt body was not in best shape to receive dose, so declined vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: elevated dimer (High) elevated dimer. On an unknown date, Computerised tomogram: unknown (Inconclusive) unknown. On an unknown date, Magnetic resonance imaging: unknown (Inconclusive) unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes Vimpat, Prednisone.  Company Comment Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This is a spontaneous report received from a contactable consumer or other non-HCP (the patient). Program ID:. A patient (no qualifiers provided) received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient had fatigue/ongoing fatigue and dizziness, with outcome of unknown. Additional information: Since the  first dose of the COVID-19 vaccine, a year ago, patient experienced ongoing fatigue and dizziness. Only since the shot, the patient had problems. The patient needed to know what is going on. Why these side effects for so long after the shot. The information on the batch/lot number for BNT162B2 requested and will be submitted if and when received.
Received both vaccinations against COVID, tested COVID + on 12/2/21. Symptoms started 11/29/21 which included increased shortness of breath, vomiting, general weakness, and cough. Hospitalized 5 days, 12/2/21-12/7/21
I was VERY T                                                                                            i         ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????  ?? ?? ??                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         SORRY about the above I'm not sure what happen tried to delete it but couldn't! I woke up Sunday 14th  at 7:30AM feeling really tired. had coffee & could barely stay awake. by 8:30AM I went back to bed woke up 11AM ish  had lunch could hardly keep my eyes open went back to bed & slept the afternoon  away. got up 5PM ish had coffee & supper still very tired I went back to bed. woke up around 10AM had something to drink & bathroom then went back to bed & slept to morning. On Monday the 15th. & Tuesday the 16th. was pretty much the same as the 14th.  On the 17th. woke up at 8:45AM FEELING GREAT! No other problem but being very tired!
Area of induration 2-3cm, total red area 6cm w/o pain on palpation. Local injection site inflammation.
patient received the 5-11 year old monovalent vaccine, rather than bivalent booster
mom called 24 hrs p/shots & said pt had low grade temp, vomited x 1 during noc & was not pale & lifeless; 27SEP mom took pt to MD & WBC was 23,000;
102 degree fever. Shaking uncontrollable. Loss of bladder. Unable to talk or comprehend.
vaccine administered was actually expired since 2/26/2023; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 13-month-old female patient who received HAV (Havrix) (batch number T57F3, expiry date 16-FEB-2023) for prophylaxis.   On 08-MAR-2023, the patient received Havrix. On 08-MAR-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: vaccine administered was actually expired since 2/26/2023).  The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 5-Sept-2023 The medical assistant reported that on the day of reporting, while going through the records, they found that the vaccine administered was actually expired. The patient was doing fine. Treating physician was aware. The reporter consented to follow-up. The patient received an expired dose of Havrix, which led to expired vaccine used.
Pt received Moderna Dose 1 on 09/22/2021. the 2nd dose was given a week early on 10/13/2021. Pt was contact post covid vaccine but no response.